Navigation Links
Hospira Announces New Contract With HealthTrust Purchasing Group for Infusion Devices, Solutions and Equipment
Date:2/26/2008

LAKE FOREST, Ill., Feb. 26 /PRNewswire-FirstCall/ -- Hospira, Inc. (NYSE: HSP), a leading global hospital products company, today announced a new national agreement with HealthTrust Purchasing Group, LP (HealthTrust). The multi-year contract will provide HealthTrust member organizations with access, on a non-exclusive basis, to Hospira's general-purpose medication infusion devices, related sets and disposables, along with intravenous (I.V.) solutions, nutritionals and drug-delivery products.

Through existing agreements, Hospira already provides pain-management infusion pumps to HealthTrust members, and infusion devices, I.V. solutions and equipment to members of Consorta -- a group purchasing organization (GPO) that joined HealthTrust in 2007.

"Hospira's products and services can help HealthTrust's members meet their goals -- from increasing patient safety to reducing costs and improving caregiver productivity," said Pete Baker, vice president and general manager, Commercial Service Operations, Hospira. "We look forward to developing strong relationships with HealthTrust's member healthcare institutions."

The new agreement includes Hospira's general-purpose medication infusion technologies, such as the Plum A+(R) and next-generation Symbiq(R) infusion systems with Hospira MedNet(R) safety software. These products play a critical role in improving patient safety as well as enhancing quality of care and clinician workflow. The contract also provides access to Hospira's I.V. solutions and associated equipment portfolio, including the company's more environmentally preferable VisIV(R) container for I.V. solutions. This contract represents the first opportunity for Hospira to provide access to these products to HealthTrust members.

About HealthTrust

HealthTrust Purchasing Group, headquartered in Brentwood, Tennessee, is a group purchasing organization that supports over 3800 not-for-profit and for-profit facilities, which include acute care hospitals, ambulatory surgery centers, physician practices, and alternate care sites. With an annual purchasing volume by its members of more than $13 billion, HealthTrust is committed to obtaining the best price for clinically-recommended products, ensuring their timely delivery and continuously evaluating and improving its services to the patients, physicians and clinicians it serves. HealthTrust is located at 155 Franklin Road, Suite 400, Brentwood, TN 37027 Website: http://www.healthtrustpg.com.

About Hospira

Hospira, Inc. is a global specialty pharmaceutical and medication delivery company dedicated to Advancing Wellness(TM). As the world leader in specialty generic injectable pharmaceuticals, Hospira offers one of the broadest portfolios of generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management solutions. Through its products, Hospira helps improve the safety, cost and productivity of patient care. The company is headquartered in Lake Forest, Ill., and has more than 14,000 employees. Learn more at http://www.hospira.com.
Private Securities Litigation Reform Act of 1995 --

A Caution Concerning Forward-Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Hospira cautions that these forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those indicated in the forward-looking statements. Economic, competitive, governmental, technological and other factors that may affect Hospira's operations and may cause actual results to be materially different from expectations include the risks and uncertainties set forth under the heading "Item 1 Business -- Risk Factors" in Hospira's Annual Report on Form 10-K for the year ended Dec. 31, 2006, filed with the Securities and Exchange Commission, which are incorporated by reference. Hospira undertakes no obligation to release publicly any revisions to forward-looking statements as the result of subsequent events or developments.


'/>"/>
SOURCE Hospira, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Hospira Hosts Conference Call for Fourth-Quarter 2007 Results and 2008 Projections
2. Hospira to Present at the JPMorgan 26th Annual Healthcare Conference on January 9
3. Hospira Reports Third-Quarter 2007 Results
4. Hospira to Present at the Credit Suisse Phoenix Health Care Conference on November 13
5. Hospira to Present at the Bear Stearns 20th Annual Healthcare Conference on September 11
6. Thomson Healthcare Announces Enhancements to Order Sets Solution
7. Heska Announces Q4 and Annual 2007 Results
8. Acuo Technologies(R) Announces a Fully Integrated XDS-I Solution
9. The Quantum Group Announces Strategic Technology Alliance
10. Bradmer announces Phase II results published in newly diagnosed glioblastoma which demonstrate improved survival and support upcoming Phase III study
11. China Bionanometer Industries Corporation Announces New Products for China
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, can now ... and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings ... The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under the ...
(Date:6/25/2016)... Oklahoma (PRWEB) , ... June 25, 2016 , ... ... both athletes and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures ... Oklahoma City area —Johnson is one of the first doctors to perform the ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World Sickle ... chronic pain and the benefits of holistic treatments, Serenity Recovery Center of ... Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of the red ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, ... and the Road To Recovery® program to drive cancer patients to and from their ... to ensure the highest quality of life and ongoing independence. Getting to and ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... client, The Grove Investment Group (TGIG), has initiated cultivation and processing operations at ... Las Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of a complete ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016 Dehaier Medical Systems ... "Company"), which develops, markets and sells medical devices and ... , signed a strategic cooperation agreement with Hongyuan Supply ... Supply Chain") on June 20, 2016, to develop Dehaier,s ... strategic cooperation agreement, Dehaier will leverage Hongyuan Supply Chain,s ...
(Date:6/24/2016)... Mass. , June 24, 2016   Pulmatrix, ... pharmaceutical company developing innovative inhaled drugs, announced today that ... Russell Investments reconstituted its comprehensive set of ... "This is an important milestone for Pulmatrix," ... will increase shareholder awareness of our progress in developing ...
(Date:6/23/2016)... Research and Markets has announced the addition of the ... report to their offering. ... failure, it replaces the function of kidneys by removing the ... the treatment helps to keep the patient body,s electrolytes such ... Increasing number of ESRD patients & substantial healthcare expenditure on ...
Breaking Medicine Technology: